Nevertheless, recent results from a large HGSOC cohort composed of 534 patients indicated that tumor B cell-derived IgA redirects myeloid cells against extracellular oncogenic drivers, which causes tumor cell death and sensitizes tumor cells to cytolytic killing by T cells (94). The gene discussed is CD79A; the disease is neoplasm.